New valve study tracks success in brain fluid disorder patients

NCT ID NCT05397106

First seen Jan 14, 2026 · Last updated Jun 09, 2026 · Updated 28 times

Summary

This study follows 160 people of any age who have or will get a CODMAN CERTAS Plus programmable valve to treat conditions like hydrocephalus, normal pressure hydrocephalus, or brain tumors. The main goal is to check that the valve is placed correctly and works well 30 days after surgery, without needing extra procedures. Researchers are monitoring device performance in real-world use to ensure safety and reliability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AZ Delta - Roeselare

    Roeselare, Belgium

  • Canton Hospital St. Gallen

    Sankt Gallen, Switzerland

  • Freiburg University Hospital

    Freiburg im Breisgau, Germany

  • Heinrich Heine University, Dept of Neurosurgery, Universitätsklinik Düsseldorf

    Düsseldorf, 40225, Germany

  • Hospital12 de Octubre

    Madrid, Spain

  • Katharinenhospital - Neurochirurgische Klinik Stuttgart

    Stuttgart, Germany

  • Klinikum Dortmund Wirbelsäulenchirurgie

    Dortmund, Germany

  • University Hospital Leuven

    Leuven, Belgium

  • Universitätsklinikum Essen

    Essen, Germany

Conditions

Explore the condition pages connected to this study.